Skip to main content

Day: February 12, 2024

Volcon Provides Video to Update Stag Launch

AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) — Volcon Inc. (NASDAQ: VLCN) (“Volcon” or the “Company”), the first all-electric, off-road powersports company posted a video to its website providing an update on the Stag launch. A link to the video is posted below:   Stag Update Video Link. About Volcon Based in the Austin, Texas area, Volcon was founded as the first all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community. Volcon electric vehicles are the future of off-roading, not only because of their environmental benefits but also because of their near-silent operation, which allows for a more immersive outdoor experience. Volcon’s vehicle roadmap includes both motorcycles and UTVs. Its first product, the innovative Grunt, began shipping to customers in late 2021...

Continue reading

VERB’s MARKET.live Announces Launch of Frankie Avalon’s Livestream Shopping Show

The Iconic Entertainer Will Present A Journey of Love, Music, and Wellness LOS ALAMITOS, Calif. and LAS VEGAS, Feb. 12, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”) is delighted to announce the launch of an extraordinary livestream shopping series on MARKET.live featuring Frankie Avalon, the entertainer beloved by generations, and co-hosted by the popular TV personality Albany Irvin. The show, the first in a series, is scheduled for Thursday, February 15, at 3 pm PST / 6 pm EST. Show Highlights:Date/Time: Thursday, Feb. 15 at 3 pm PST/6 pm EST Hosts: FRANKIE AVALON, with co-host Albany Irvin (albanyirvin.com) Product: Fruit and Veggie SupplementsShow Theme: A Journey of Love, Music, and Wellness Join Frankie Avalon on a captivating journey through his...

Continue reading

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases

Poster presentation unveils Corvus’ next-generation ITK inhibitor candidates designed to deliver precise T cell modulation for immunology indicationsFigure 1Venn diagram illustrating different biological properties of the next-gen ITK inhibitors in T cell differentiation assays.BURLINGAME, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that preclinical data for soquelitinib, the Company’s lead ITK inhibitor program, was presented in a poster session at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases, which took place February 8-11, 2024. The poster presentation includes the first description of Corvus’ next-generation ITK inhibitor preclinical product candidates, which were designed to deliver...

Continue reading

One Big Step for Bioelectronic Implant Developers Including US Nuclear’s Partner Grapheton

LOS ANGELES, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — On January 29, 2024, an innovative brain implant company reached a new company milestone by surgically implanting electrodes in the brain of their first human subject, thus signaling the opening of a new age and a new industry for companies such as Grapheton. US Nuclear (OTC-QB: UCLE) is proud to be Grapheton’s partner and largest investor, and is incredibly excited about their potential to revolutionize therapies for disabled people of every sort. Grapheton has developed cutting-edge bioelectronic implants aimed at treating various ailments such as cardiac abnormalities, chronic pain, Parkinson’s disease, and hearing loss, taking their technology a step further by using next-generation carbon-based material and multi-modal probes that read both electrical...

Continue reading

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)

FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) — The Company holds a U.S. patent for the same treatment via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that it received an Australian patent, valid until 2040, Application No. 2021314052, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, used in the Company’s asset ABV-1504 for the treatment of Major Depressive Disorder (MDD). The Company was previously awarded a U.S. patent, US 11,554,154 B2, on April 25, 2023, for the same treatment. “These patents grant ABVC the right to exclude others from using, offering, or selling PDC-1421 throughout the United States and Australia...

Continue reading

Global Hybrid Operating Room Market to Surpass 1.49 Billion by 2030 Driven by Rising Demand for Advanced Surgical Procedures

SkyQuest projects that the global hybrid operating room market will attain a value of USD 1.49 billion by 2030, with a CAGR of 12.9% during the forecast period (2023-2030). The global hybrid operating room market is currently undergoing a remarkable surge in growth, primarily propelled by the escalating demand for advanced surgical procedures and the seamless integration of cutting-edge medical technologies. This surge is further amplified by the rising prevalence of chronic diseases and age-related conditions, driving the need for innovative medical solutions. Westford USA, Feb. 12, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the global hybrid operating room market’s growth is significantly bolstered by ongoing advancements in medical imaging technologies, including integrating 3D imaging, robotic-assisted surgery, and...

Continue reading

Christina Lake Cannabis Completes Acquisition

VANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:CLB), (the “Company” or “Christina Lake Cannabis” or “CLC”), a leading producer of high quality extracts and sun grown cannabis, is pleased to announce it has completed the acquisition of certain assets from a private British Columbia corporation (the “Vendor”). The previously announced transaction includes acquiring ownership of outdoor cultivation facilities in Midway, British Columbia, related harvesting and manufacturing equipment, and approximately 19,000 kg. of biomass (the “Transaction”) for a total purchase price of $3,000,000 (the “Purchase Price”). “This acquisition will solidify our position as a key supplier to the country’s top brands,” said Mark Aiken,...

Continue reading

IBEX Technologies Signs Definitive Agreement for Sale of the Company for $1.45 Cash Per Share

MONTREAL, Feb. 12, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that it has entered into a binding acquisition agreement dated February 9, 2024 (the “Acquisition Agreement”) and related agreements with 15720273 Canada Inc. (the “Purchaser”), a newly-incorporated, wholly-owned subsidiary of BBI Solutions OEM Limited (“BBI”), whereby BBI will acquire all of the issued and outstanding shares of IBEX at a price of $1.45 per share in cash. The transaction will be effected by way of an amalgamation of IBEX and the Purchaser under the Canada Business Corporations Act (the “Amalgamation”) to form an amalgamated corporation (“Amalco”). Under the Amalgamation, each issued and outstanding common share of IBEX will be exchanged for one redeemable preferred share of Amalco,...

Continue reading

Global Pipe Insulation Market to Reach Value of USD 14.86 Billion by 2030 | Skyquest Technology

Global pipe insulation market is segmented based on insulation material, end user, and application. The market is segmented by insulation material into fiberglass, mineral wool, and others. By end user, the market is segmented into residential, commercial, and industrial. By application, the market is segmented into HVAC (heating, ventilation, and air conditioning), oil and gas, chemical, power generation, and food processing- Industry forecast 2023-2030 Westford,USA, Feb. 12, 2024 (GLOBE NEWSWIRE) — According to SkyQuest report, the global pipe insulation market is experiencing robust growth, primarily fueled by the escalating need for energy efficiency, sustainability, and thermal insulation in diverse industries. Stringent regulations and policies geared toward curbing greenhouse gas emissions and curbing energy consumption...

Continue reading

Form 8.3 – [YOUNG & CO.’S BREWERY PLC 09 02 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree YOUNG & CO.’S BREWERY PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.